About Leiden Drug Development Conference

The development and production of medicines in the Benelux has always been followed with great interest, with the Covid-19 pandemic placing it in the spotlight. In recent years it has become eminent that the availability of medicines cannot always be guaranteed. 

The Leiden Bio Science Park (LBSP) has become the largest LSH cluster in the Netherlands and also has a strong international position. With its diversity of parties - including research and educational institutions, an academic hospital and a selection of starters and internationally active companies that focus on health in general and drug development in particular – the LBSP represents a unique innovation district. The LBSP is integrated in the landscape of education, business, healthcare and science in the province of South Holland. During the Leiden Drug Development Conference we aim to advance interactions between the various participants on the complexity of the development, production, distribution and use of medicines.

The 2026 edition of LDDC is in conjunction with Figon Dutch Medicines Days on 7 & 8 October 2026. The 2-day programme of this combined conference offers high-level plenary lectures, various parallel sessions where the different member organizations present their research.